Elanco Animal Health Inc
ELAN · XNYSCIK 1739104fmd_1DMA99XY8YA5FF2906FM6EV2V3Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2016 to Sep 30, 2026, 40 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 2,914 | 2,889 | 3,067 | 3,071 | 3,271 | 4,764 | 4,411 | 4,417 | 4,439 | 4,715 |
| Cost of revenue | 1,409 | 1,494 | 1,574 | 1,470 | 1,667 | 2,132 | 1,913 | 1,931 | 2,003 | 2,122 |
| Gross profit | 1,505 | 1,395 | 1,493 | 1,601 | 1,604 | 2,632 | 2,498 | 2,486 | 2,436 | 2,593 |
| Research and development | 266 | 252 | 247 | 270 | 329 | 369 | 321 | 327 | 344 | 368 |
| Selling, general and administrative | 785 | 780 | 735 | 760 | 997 | 1,403 | 1,265 | 1,285 | 1,314 | 1,430 |
| Interest expense | 0 | 0 | 30 | 79 | 150 | 236 | 241 | 277 | 235 | 220 |
| Interest and investment income | – | – | – | – | – | – | – | 4 | 31 | 43 |
| Other non-operating income (expense) | 3 | 0 | (41) | (28) | 178 | (5) | (32) | (75) | – | – |
| Income before taxes | (22) | (233) | 114 | 78 | (677) | (571) | (72) | (1,195) | 488 | (224) |
| Income tax expense | 26 | 78 | 28 | 10 | (103) | (88) | 6 | 36 | 150 | 8 |
| Net income from continuing operations | (48) | (311) | 87 | 68 | (574) | (483) | (78) | (1,231) | 338 | (232) |
| Net income | (48) | (311) | 87 | 68 | (574) | (483) | (78) | (1,231) | 338 | (232) |